STOCK TITAN

Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Codexis, Inc. (CDXS) will report its financial results for Q4 and FY 2023 on February 28, 2024. The company will host a conference call to discuss the results and provide a business update.
Positive
  • None.
Negative
  • None.

REDWOOD CITY, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the fourth quarter and fiscal year 2023 on Wednesday, February 28, 2024, following the close of market. Codexis management will host a conference call and webcast at 4:30 pm Eastern Time to discuss the Company’s financial results and provide a business update.

Participants may access the live webcast on the Codexis Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing 877-705-2976 (domestic) or 201-689-8798 (international). A telephone replay of the call will be available for 48 hours by dialing 877-660-6853 (domestic) or 201-612-7415 (international), access ID #13726635.

About Codexis
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit www.codexis.com.

For More Information

Investor Contact
Carrie McKim
(336) 608-9706
ir@codexis.com

Media Contact
Lauren Musto
(650) 421-8205
media@codexis.com

 


FAQ

When will Codexis, Inc. report its financial results for Q4 and FY 2023?

Codexis, Inc. (CDXS) will report its financial results for the fourth quarter and fiscal year 2023 on Wednesday, February 28, 2024.

What time will the conference call and webcast be held?

The conference call and webcast will be held at 4:30 pm Eastern Time.

How can participants access the live webcast?

Participants may access the live webcast on the Codexis Investor Relations website.

How long will the webcast be available for viewing?

The webcast will be archived for 90 days on the Codexis Investor Relations website.

How can participants access the live call?

The live call can be accessed by dialing 877-705-2976 (domestic) or 201-689-8798 (international).

How long will the telephone replay of the call be available?

A telephone replay of the call will be available for 48 hours by dialing 877-660-6853 (domestic) or 201-612-7415 (international), access ID #13726635.

Codexis, Inc.

NASDAQ:CDXS

CDXS Rankings

CDXS Latest News

CDXS Stock Data

365.39M
79.57M
2.23%
79.83%
2.4%
Biotechnology
Industrial Organic Chemicals
Link
United States of America
REDWOOD CITY